164 related articles for article (PubMed ID: 17705416)
21. Bisphosphonate-functionalized hyaluronic acid showing selective affinity for osteoclasts as a potential treatment for osteoporosis.
Kootala S; Ossipov D; van den Beucken JJ; Leeuwenburgh S; Hilborn J
Biomater Sci; 2015 Aug; 3(8):1197-207. PubMed ID: 26222035
[TBL] [Abstract][Full Text] [Related]
22. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.
Sacco SM; Jiang JM; Reza-López S; Ma DW; Thompson LU; Ward WE
Menopause; 2009; 16(3):545-54. PubMed ID: 19182694
[TBL] [Abstract][Full Text] [Related]
23. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
[TBL] [Abstract][Full Text] [Related]
24. A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts.
Liu J; Dang L; Li D; Liang C; He X; Wu H; Qian A; Yang Z; Au DW; Chiang MW; Zhang BT; Han Q; Yue KK; Zhang H; Lv C; Pan X; Xu J; Bian Z; Shang P; Tan W; Liang Z; Guo B; Lu A; Zhang G
Biomaterials; 2015 Jun; 52():148-60. PubMed ID: 25818421
[TBL] [Abstract][Full Text] [Related]
25. The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model.
Takahata M; Ito M; Abe Y; Abumi K; Minami A
Bone; 2008 Dec; 43(6):1057-66. PubMed ID: 18835375
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of alendronate: an overview.
Lin JH; Russell G; Gertz B
Int J Clin Pract Suppl; 1999 Apr; 101():18-26. PubMed ID: 12669737
[TBL] [Abstract][Full Text] [Related]
27. Cathepsin K inhibitors: a novel target for osteoporosis therapy.
Stoch SA; Wagner JA
Clin Pharmacol Ther; 2008 Jan; 83(1):172-6. PubMed ID: 18073778
[TBL] [Abstract][Full Text] [Related]
28. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
29. [Assessment of bone quality. Bone quality and osteoporosis treatment].
Mashiba T
Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
[TBL] [Abstract][Full Text] [Related]
30. [Changes of the content of hydroxyapatite and collagen in bone tissue of ovariectomized rats].
Pang W; Kang L; Fu YL; Yu XD; Wang QY
Zhongguo Gu Shang; 2011 May; 24(5):424-5. PubMed ID: 21688546
[No Abstract] [Full Text] [Related]
31. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
Gangoiti MV; Cortizo AM; Arnol V; Felice JI; McCarthy AD
Eur J Pharmacol; 2008 Dec; 600(1-3):140-7. PubMed ID: 18973752
[TBL] [Abstract][Full Text] [Related]
32. The effects of systemic alendronate with or without intraalveolar collagen sponges on postextractive bone resorption: a single masked randomized clinical trial.
Graziani F; Rosini S; Cei S; La Ferla F; Gabriele M
J Craniofac Surg; 2008 Jul; 19(4):1061-6. PubMed ID: 18650733
[TBL] [Abstract][Full Text] [Related]
33. Osteotropic beta-cyclodextrin for local bone regeneration.
Liu XM; Wiswall AT; Rutledge JE; Akhter MP; Cullen DM; Reinhardt RA; Wang D
Biomaterials; 2008 Apr; 29(11):1686-92. PubMed ID: 18199479
[TBL] [Abstract][Full Text] [Related]
34. Major phenolic compounds in olive oil modulate bone loss in an ovariectomy/inflammation experimental model.
Puel C; Mardon J; Agalias A; Davicco MJ; Lebecque P; Mazur A; Horcajada MN; Skaltsounis AL; Coxam V
J Agric Food Chem; 2008 Oct; 56(20):9417-22. PubMed ID: 18800805
[TBL] [Abstract][Full Text] [Related]
35. A bone-targeting delivery system carrying osteogenic phytomolecule icaritin prevents osteoporosis in mice.
Huang L; Wang X; Cao H; Li L; Chow DH; Tian L; Wu H; Zhang J; Wang N; Zheng L; Yao X; Yang Z; Qin L
Biomaterials; 2018 Nov; 182():58-71. PubMed ID: 30107270
[TBL] [Abstract][Full Text] [Related]
36. Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
Zikan V; Stepan JJ
Bone; 2009 Apr; 44(4):634-8. PubMed ID: 19150421
[TBL] [Abstract][Full Text] [Related]
37. Effects of alendronate on tooth eruption and molar root formation in young growing rats.
Bradaschia-Correa V; Massa LF; Arana-Chavez VE
Cell Tissue Res; 2007 Dec; 330(3):475-85. PubMed ID: 17901984
[TBL] [Abstract][Full Text] [Related]
38. Improvement in bone strength parameters. The role of strontium ranelate.
Tournis S
J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
[TBL] [Abstract][Full Text] [Related]
40. Skeletal function and structure: implications for tissue-targeted therapeutics.
Shea JE; Miller SC
Adv Drug Deliv Rev; 2005 May; 57(7):945-57. PubMed ID: 15876397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
